AEE
53
-5
PLD
40
-8
TGNA
58
2
ALLE
41
-9
RCL
73
-3
BIIB
46
-3
CNP
55
-2
VFC
72
-4
VRSK
25
-3
CF
42
-6
CNX
49
-3
ADT
48
-2
CSX
48
-2
ACN
52
-2
MET
64
-2
DOW
38
-2
HUM
34
-8
DRI
56
-2
AMAT
50
-2
ORLY
40
-4
AEE
53
-5
PLD
40
-8
TGNA
58
2
ALLE
41
-9
RCL
73
-3
BIIB
46
-3
CNP
55
-2
VFC
72
-4
VRSK
25
-3
CF
42
-6
CNX
49
-3
ADT
48
-2
CSX
48
-2
ACN
52
-2
MET
64
-2
DOW
38
-2
HUM
34
-8
DRI
56
-2
AMAT
50
-2
ORLY
40
-4
Financhill
Back

Invesco Active US Real Estate ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
38

PSR
Invesco Active US Real Estate ETF

Last Price:
$91.02
Seasonality Move:
1.22%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.64
Seasonality Move:
11.58%
Sell
38
Invesco Active US Real Estate ETF (PSR) is a Sell

Is Invesco Active US Real Estate ETF a Buy, Sell or Hold?

  • The current Invesco Active US Real Estate ETF [PSR] share price is $90.71. The Score for PSR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • PSR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSR Stock Price Chart

What is Invesco Active US Real Estate ETF's stock price today?

  • The Invesco Active US Real Estate ETF share price today is $90.71
    The current trend is relatively stagnant and PSR is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

PSR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 44.24 Sell
Chaikin Money Flow: -568 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

PSR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.99 Sell
20-day SMA: 91.35 Sell
50-day SMA: 91.73 Sell
200-day SMA: 91.59 Sell
8-day EMA: 91.07 Sell
20-day EMA: 91.31 Sell
50-day EMA: 89.78 Buy
200-day EMA: 57.33 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Invesco Active US Real Estate ETF Earnings Growth & PSR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Invesco Active US Real Estate ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):